Litcius/Paper detail

4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation

Pavel Osmančík, Dalibor Heřman, Petr Neužil, Pavel Hála, Miloš Táborský, Petr Kala, Martin Poloczek, Josef Šťásek, Luděk Haman, Marian Branny, Jan Chovančík, Pavel Červinka, Jiří Holý, Tomáš Kovárník, David Zemánek, Štěpán Havránek, V. Vančura, Petr Peichl, Petr Toušek, Veronika Lekešová, Jiří Jarkovský, Martina Nováčková, Klára Benešová, Petr Widimský, Vivek Y. Reddy

2021Journal of the American College of Cardiology275 citationsDOI

Topics & Concepts

MedicineAtrial fibrillationStroke (engine)CardiologyInternal medicineClinical endpointApixabanRandomized controlled trialPercutaneousAtrial AppendageEmbolismLeft atrial appendage occlusionSurgeryRivaroxabanWarfarinMechanical engineeringEngineeringSinus rhythmAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiovascular Disease and Adiposity
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation | Litcius